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New advances in directing the neuronal differentiation of human embryonic and induced
pluripotent stem cells (hPSCs, abbreviation intended to convey both categories of
pluripotent stem cells) have promoted the development of culture systems capable of
modeling early neurogenesis and neural specification at some of their critical milestones.
The hPSC-derived neural rosette can be considered the in vitro counterpart of the
developing neural tube, since both structures share a virtually equivalent architecture and
related functional properties. Epigenetic stimulation methods can modulate the identity of
the rosette neural progenitors in order to generate authentic neuronal subtypes, as well
as a full spectrum of neural crest derivatives. The intrinsic capacity of induced pluripotent
cell-derived neural tissue to self-organize has become fully apparent with the emergence
of innovative in vitro systems that are able to shape the neuronal differentiation of hPSCs
into organized tissues that develop in three dimensions. However, significant hurdles
remain that must be completely solved in order to facilitate the use of hPSCs in modeling
(e.g., late-onset disorders) or in building therapeutic strategies for cell replacement. In
this direction, new procedures have been established to promote the maturation and
functionality of hPSC-derived neurons. Meanwhile, new methods to accelerate the aging
of in vitro differentiating cells are still in development. hPSC-based technology has matured
enough to offer a significant and reliable model system for early and late neurogenesis that
could be extremely informative for the study of the physiological and pathological events
that occur during this process. Thus, full exploitation of this cellular system can provide
a better understanding of the physiological events that shape human brain structures, as
well as a solid platform to investigate the pathological mechanisms at the root of human
diseases.
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USING hPSC-DERIVED ROSETTE FORMATION TO MODEL
EARLY NEURULATION PROCESSES
The unique developmental potential and replicative capacity
of hPSCs offers a nearly unlimited source of specific somatic
cell types that can be exploited for in vitro mechanistic stud-
ies or cell transplantation therapies. Remarkably, neuronal cells
were among the first lineages to be differentiated using hPSCs
(Reubinoff et al., 2001; Zhang et al., 2001). Neuronal induc-
tion was first obtained by promoting the differentiation of
hPSCs in aggregate-like embryoid bodies. Subsequently, aggre-
gates were placed in stringent serum-free culture conditions,
which selectively facilitate the survival and growth of neural
cells. This transition toward the neural lineage is readily mani-
fested in hPSCs (but not in their murine counterparts) because
of the appearance of rosette-like structures within the differ-
entiating hPSC colonies (Reubinoff et al., 2001; Zhang et al.,
2001). These structures develop from progenitor cells, which
line up close together to form a round, columnar epithelium
that is reminiscent of blooming rosettes when viewed under
bright light.
Further examination of these structures revealed that the
rosettes are formed from neural progenitors. These neural
progenitors are endowed with highly polarized morphology,
as indicated by the presence of tight and adherence junc-
tions at the side facing the internal lumen, while the external
side is strongly enriched in laminin-rich extracellular matrix
(Lazzari et al., 2006; Elkabetz et al., 2008; Colleoni et al., 2010).
This architecture recapitulates the cellular organization of the
neural tube, the embryonic primordium of the entire central
nervous system (CNS), in both shape and function. In fact,
within rosettes, the nuclei of neural progenitor cells undergo
a stereotyped movement known as interkinetic nuclear migra-
tion, which is harmonized to the cell cycle stage and specific
to authentic neural tube cells (Taverna and Huttner, 2010).
Nuclei undergoing DNA synthesis localize at the outer edge
of the neural tube, while mitotic divisions are confined to its
innermost core, a pattern replicated in the same sequence by
nuclei within the rosettes (Lazzari et al., 2006; Elkabetz et al.,
2008; Colleoni et al., 2010). Therefore, rosettes share the same
elementary organization of the developing neural tube; hence,
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they are equivalent to the developing neural tube with respect
to structure and function (Figure 1). Rosette neural progeni-
tors intertwine to create overlapping cellular layers; however,
they remain constrained to the surface where they anchor. How
rosettes can be adapted to the three-dimensional (3D) space,
and which morphology and growth pattern they will follow in
these culture conditions, have not yet been ascertained. This
setting might enable the in vitro reproduction not only of neu-
ral tube organization, but also (and even more challenging) its
organogenesis.
During development, the neural tube is highly patterned along
the anterior-posterior and ventral-dorsal axes (Muñoz-Sanjuán
and Brivanlou, 2002). In particular, its anterior portion is invari-
ably committed to give rise to the different brain regions. It is
worth noting that neural rosettes, when cultured in the men-
tioned culture conditions, acquire a specific regional code that
coincides with the anterior-dorsal section of the developing neu-
ral tube, as demonstrated by the acquisition of a specific set of
regional molecular markers (Elkabetz et al., 2008; Colleoni et al.,
2010; Hu et al., 2010) (Figure 1). Considering that rosettes are
induced in amedium that lacks anymolecular inducer, these find-
ings suggest that the commitment of the anterior-dorsal region
represents the default state during neuronal induction, and only
subsequent inductive clues, either cell or non-cell autonomous,
might override this basal state, imposing other regional
identities.
FROM NEURAL TUBE-LIKE ROSETTES TO NEURAL CREST
CELL PROGENITORS
In serum-free neurobasal culture conditions, each differentiat-
ing hPSC rosette is scattered in an array of disorganized and
unpatterned cells. Remarkably, the expression of two specific
markers (p75 and HNK1) identified many of these cells as neural
crest cells (Lazzari et al., 2006; Gossrau et al., 2007; Lee et al.,
2007, 2010). Molecular analyses corroborated the acquisition of
the neural crest identity, as shown by expression of the associ-
ated molecular determinants. Temporal analysis illustrated how
neural crest cells originated by delaminating from rosette struc-
tures in a process similar to the epithelial-mesenchymal transi-
tion (EMT), which normally occurs during development when
nascent neural crest cells arise from the neural tube (Curchoe
et al., 2010). Spontaneous emergence of the neural crest com-
ponent in vitro provides additional evidence that PSC-derived
rosette structures acquire dorsal identity, since this is the side of
the neural tube from which the neural crest is selectively induced
during development (Le Douarin et al., 2004).
In agreement with this view, treatment of rosettes with Sonic
hedgehog (Shh), a ventralizing morphogen expressed by the floor
plate of the ventral neural tube, inhibits the expression of neural
crest-specific genes while activating ventral neural tube markers
(Colleoni et al., 2010). More importantly, subsequent culturing
of neuralized hPSC colonies that had been exposed to epigenetic
stimulation with the growth factors bFGF and EGF enabled the
FIGURE 1 | Induction and differentiation of iPSC-derived rosette neural
progenitors. (A) Modulation of neurodevelopmental molecular pathways by
different combinations of small molecules can direct hPSCs into rosette neural
progenitors with different positional identities along the developing neural
tube. (B) The hPSCs-derived rosette and the neural tube share the same spatial
organization showing cells with a remarkable polarization and cell-junction
compartmentalization. In addition, relative nuclei position is depending by the
cell-cycle stage in both systems. (C) According to their specific early commit-
ment, hPSCs-derived rosette neural progenitors generate distinct neuronal
sub-types and, in the case of hNCPCs, even non-neuronal somatic cells.
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generation of stable cell lines of human neural crest progeni-
tor cells (hNCPCs) (Lazzari et al., 2006; Lee et al., 2007, 2010;
Colleoni et al., 2010). hPSC-derived hNCPCs exhibited a stable
phenotype, even after sustained proliferation in vitro andmultiple
single cell disaggregation passages.
Notably, although hPSC colonies initially included CNS-like
rosette progenitors, the rosette progenitors stopped multiply-
ing and died out over few passages, giving rise to a popula-
tion of pure hNCPCs (Colleoni et al., 2010). This probably
occurred because rosette neural progenitors are extensively polar-
ized epithelial cells, and therefore are susceptible to cell death
upon single cell dissociation. Conversely, hNCPCs retained an
intrinsic resilience to cell death that might have been gained with
the EMT process and the acquirement of mesenchymal-like cell
properties (Vega et al., 2004; Robson et al., 2006). Interestingly,
the withdrawal of mitogens induced cell cycle exit and the dif-
ferentiation of neural crest progenitors into an array of somatic
cells, including sympathetic and sensory neurons, glial cells,
melanocytes, myofibroblasts, cartilage, and bone cells (Lee et al.,
2007; Colleoni et al., 2010). Although neural lineages are well
represented, their in vitro maturation is a weeks-long process.
In addition, glial cells progressed to a Schwann cell progeni-
tor stage; these progenitors were positive for S100β and GFAP,
although no sign of occurring myelination was ever detected
(Lee et al., 2007; Colleoni et al., 2010). Therefore, it remains
unknown whether hPSC-derived Schwann cells can be induced
to differentiate, or whether they are able to generate functional
myelin sheaths around axonal tracts. Clarification of this point
will enable the establishment of a valuable model of human
myelination.
Furthermore, taking into consideration other neural crest
derivatives, an interesting study has recently determined the
experimental conditions necessary for thematuration and enrich-
ment of melanocytes from differentiating hNCPCs (Mica et al.,
2013). Finally, mesodermal derivatives, including cartilage and
bone, have been equally generated from hNCPCs (Lee et al., 2007;
Colleoni et al., 2010). This finding may be of great interest for
regenerative therapies, exploiting bone and cartilage replacement
to treat, for example, trauma or osteoporosis. However, to con-
tinue along this direction, it is necessary to address the quality
and type of cartilage that hNCPCs are able to generate, as well
as (even more importantly) its stability, robustness, and longevity
after in vivo transplantation.
The induction of both neural and mesenchymal cell lineages
indicates that hPSC- derived NCPCs acquire a cranial identity in
culture, because only head neural crest contributes to mesoderm-
derived structures in the embryo (Le Douarin et al., 2004).
Remarkably, clonal analysis identified hNCPCs with mesodermal
and/or ectodermal potential similar to what has been described
regarding hPSC-derived neural crest cells (Baroffio et al., 1991;
Lee et al., 2007). However, different culture conditions or dura-
tions in culture can strongly drive hNCPCs from a neural to
a mesenchymal phenotype (Lee et al., 2007; our unpublished
results). Indeed, the exposure of hNCPCs to a serum-containing
medium upregulated mesenchymal markers (e.g., CD73) and
stimulated their differentiation into mesodermal derivatives (e.g.,
smooth muscle, cartilage, and bone cells) (Lee et al., 2007).
Therefore, hNCPCs represent an ideal cellular system in which to
investigate the molecular mechanisms that regulate this dual cell
fate potential, as well as their subsequent final differentiation into
a variety of distinct cell types.
LONG-LASTING NEURONAL PROGENITORS CELLS (hNPCs)
While isolating and expanding hNCPCs from hPSC-derived neu-
ral rosettes is a straightforward process, the generation of hNPCs
is unfortunately hampered by their low survival rate upon rosette
dissociation (Elkabetz et al., 2008; Koch et al., 2009). However,
this hurdle has been significantly attenuated by the introduc-
tion of the Rho-associated protein kinase (ROCK) inhibitor Y-
27632, which inhibits single-cell-induced death (Watanabe et al.,
2007). hNPCs, which are capable of extensive self-renewal, clono-
genicity, and multipotency, have been derived from rosettes by
generating neurosphere-like floating aggregates or monolayer
cultures (Zhang et al., 2001; Conti et al., 2005). The purity
of hNPC cultures has yet to be convincingly assessed, and
might be jeopardized by the presence of contaminating hNCPCs.
This is an important caveat because many protocols rely on
the manual isolation of rosettes, and therefore likely permit
the incorporation of closely abutting hNCPCs, which can eas-
ily outnumber the hNPCs owing to their better survival and
growth rate in the same culture conditions. Taking all of this
into consideration, it is always worthwhile to test the presence
of p75+ cells in hNPC cultures in order to verify neural crest
cell contaminants. Kim et al. (2012) have conceived a valu-
able approach to prevent such contamination; they demonstrated
that polysialylated-neural cell adhesion molecule is strongly
enriched in rosette hNPCs, and thus cell sorting for this epitope
enables the isolation of a pure population, devoid of any cellular
contaminants.
The polysialylated-neural cell adhesion molecule-negative cell
fraction is mainly comprised of hNCPCs, thus providing an
approach to purify both cells types in a single-step procedure
(Kim et al., 2012). Moreover, long-lasting proliferative hNPCs
represent a renewable source of neurons and glia that, once
established, is independent of hPSC culture. However, growth
factor-dependent hNPC expansion might also lead to unde-
sired effects. Indeed, Bilican et al. (2014) noted that chronic
exposure to EGF might cause NPCs to lose their anterior iden-
tity while assuming a hindbrain regional code. Interestingly, the
expansion of hNPCs in the presence of bFGF and physiological
levels (3%) of O2, is sufficient to enable long-term prolifera-
tion while maintaining the anterior character that is fundamental
for stable differentiation of committed cortical neurons. How
hNPCs are able to modify their competent state with respect to
regional specification and give rise to different neuronal subtypes
is still unclear. Some reports suggest that early hNPCs might
still respond to inductive signals in order to acquire a different
regional identity (Koch et al., 2009); however, they are unlikely
to be able to maintain this capability without change over time
and after extensive cell passaging. Given these last observations,
several procedures have been established with the aim of gen-
erating a single neuronal subtype using direct differentiation of
hPSC-derived neural rosettes, some of which are described in the
next Section.
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CORTICAL NEURONS
Although neural rosettes exhibit a default anterior regional code,
their dissociation and subsequent neuronal differentiation in
standard culture conditions (e.g., absence of morphogen sup-
plementation) leads to a population of mature neurons that
are representative of various brain regions. However, prolonged
exposure to the BMP inhibitor Noggin is sufficient to effi-
ciently induce differentiationmainly of cortical neurons (Espuny-
Camacho et al., 2013) (Figure 1). In addition, the presence of
retinoids (retinol-acetate and all-trans retinol) during neural
induction and differentiation maximizes the conversion of corti-
cal neurons (Shi et al., 2012). Both procedures converge on the
progression of cortical neuronal differentiation with the initial
generation of deep layer neurons; superficial layer neurons are
generated later, during the development of the cerebral cortex.
Therefore, the temporal sequence of neuronal subtype specifica-
tion in this system mirrors the in vivo occurrence of the same
process (Greig et al., 2013). Based on these data, one can envisage
that this pattern of in vitro neurogenesis is mainlymediated by cell
autonomous mechanisms, which might be intrinsically encoded
within the neuronal progenitors. The generation of both deep and
upper cortical neurons from hPSCs covers a very extensive time-
frame, which might last for up to 3 months of culture, which
dovetails with the delay in cortical neurogenesis that occurs in
human embryos compared with mouse embryos (Shi et al., 2012;
Espuny-Camacho et al., 2013). More importantly, hPSC-derived
cortical neurons grafted into the frontal cortex of the neonatal
brain were able to survive, mature, and extend their axons to
the proper neuronal targets according to their layer specification
(Espuny-Camacho et al., 2013). These data indicate that the use
of this in vitro system enables the full acquisition of subtype iden-
tity, which is then fully elaborated after transplantation. Finally,
the grafted human neurons developed functional properties and
synaptic connectivity within 3 months after transplantation. It
would be of great interest to challenge the transplantation of these
neurons in healthy and injured adult brain, in order to verify
whether they are able to mature and functionally integrate even
in more prohibitive conditions.
GABAergic NEURONS
In contrast to excitatory (glutamatergic) cortical pyramidal neu-
rons that project long distance, inhibitory (GABAergic) corti-
cal interneurons make local synapses and are essential for the
maintenance of balanced activity within neural circuits (Marín,
2013; Kepecs and Fishell, 2014). Interneuronal dysfunctions have
been described in several disorders, including epilepsy, autism,
schizophrenia, and Tourette’s syndrome (Valiente and Marín,
2010; Alvarez Dolado and Broccoli, 2011; Marín, 2012). The
direct differentiation of hPSCs into telencephalic GABAergic neu-
rons has been achieved recently (Maroof et al., 2013; Nicholas
et al., 2013). In both studies, early telencephalic GABAergic com-
mitment of hPSCs was reported by the expression of green fluo-
rescent protein (GFP) under the control of the Nkx2.1 promoter,
which is fundamental for setting up the appropriate conditions
for the specification of this neuronal subtype. In fact, optimal
conditions were attained by combining exposure to BMP and
Wnt inhibitors, which prime telencephalic identity, with Shh
signaling stimulation, which induces ventral neuronal charac-
ter, thus reaching up to 70% of Nkx2.1-GFP-positive, hPSC-
derived, GABAergic neuronal precursors (Figure 1). Cortical
interneurons include a different set of neuron types that have
distinct roles in cortical development and function (Marín,
2013; Kepecs and Fishell, 2014). In these conditions, the preva-
lence of somatostatin-positive cells was observed, while many
fewer interneurons expressing parvalbumin or VIP were detected.
Thus, more work is needed to identify permissive conditions
for the effective derivation of the later subtypes. Co-cultures
with astrocytes or hippocampal neurons promoted hPSC-derived
GABAergic neuronal maturation and functionality, including
repetitive action potential firing, ionic channel currents, and
synaptic currents. To directly prove their inhibitory synaptic
activity, GABAergic neurons were excited by an optogenetic pro-
tocol that evoked robust postsynaptic currents in neighboring
neurons, which were sensitive to the GABA antagonist bicuculline
(Nicholas et al., 2013). Thus, hPSCs can be induced to differ-
entiate into functional inhibitory GABAergic interneurons. It is
interesting to point out that upon transplantation into neonatal
brains, a fraction of the grafted neurons matured in the host neu-
ral tissue, gaining functional properties and synaptic connectivity,
although several months of engraftment were required (Nicholas
et al., 2013). These last results are particularly compelling in light
of the fact that the transplantation of mouse native GABAergic
precursors has proven therapeutic in treating animal models of
epilepsy, schizophrenia, and Parkinson’s disease (PD) (Southwell
et al., 2014; Tyson and Anderson, 2014). All of these different
pathological conditions have benefited fromGABAergic neuronal
transplantation, likely because it favors the re-organization of the
neuronal circuit connections and the re-establishment of the cor-
rect balance between excitation and inhibition in cortical circuits
(Southwell et al., 2014; Tyson and Anderson, 2014). In particular,
this approach might have a straightforward application regarding
the many forms of epilepsy that eventually reach an irreversible,
drug-resistant stage.
DOPAMINERGIC NEURONS
Substantia nigra (A9) midbrain dopaminergic neurons are specif-
ically lost during the initial phase of PD. The consequent loss of
dopamine availability in striatal tissue is responsible for the trou-
blesome motor impairments that severely affect PD patients. In
fact, most of the drugs used to treat PD aim simply to restore suf-
ficient levels of dopamine in the striatum, but cannot reverse or
block the loss of dopaminergic neurons (Meissner et al., 2011).
In this context, dopamine neuron replacement has been envi-
sioned as a potential therapeutic strategy during the last decades
(Dunnett et al., 2001; Lindvall and Björklund, 2011).
Transplantation of midbrain human fetal tissue provided a
solid basis for a cellular approach to PD, confirming the ability of
transplanted neurons to integrate into the host striatal tissues and
sustain functional integration and a therapeutic effect (Barker
et al., 2013). However, this approach had little clinical benefit,
mainly because of the broad cell heterogeneity of the transplanted
tissue, its minimal availability, and scarce immuno-compatibility
(Lindvall and Björklund, 2004; Barker et al., 2013). Even worse,
these issues were responsible for the development of the troubling
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side effect of graft-induced dyskinesia, which is experienced by
some of the patients (Lane et al., 2010).
Given this context, hPSCs have long been considered a bet-
ter renewable source of dopamine neurons that could potentially
overcome these hurdles. To this purpose, many protocols have
been developed for the in vitro differentiation of hPSCs into
this particular class of neurons. Combined exposure to the mor-
phogens Shh and FGF8, known to contribute to ventral midbrain
neural commitment in the developing neural tube, was also found
to instruct mouse and human PSCs to differentiate into tyro-
sine hydroxylase (TH)-positive dopamine neurons (Kim et al.,
2002; Perrier et al., 2004; Lee et al., 2009) (Figure 1). However,
the brain contains distinct dopamine neuronal clusters that dif-
fer with regard to function, connectivity, and molecular marker
expression. This is a crucial issue because only transplantation of
A9 [and not, for example, VTA (A10)] resident dopamine neu-
rons can achieve maximal behavioral recovery in a mouse model
of PD (Grealish et al., 2010). Reasonable graft-induced recovery
depends on the correct innervation (and thereby the functional
activation) of the striatum, which represents the physiological tar-
get structure of A9, but not A10, dopamine neurons (Grealish
et al., 2010).
These results have far-reaching implications, indicating that
the therapeutic benefits of cell transplantation approaches depend
on the replacement of native neurons with cells that are close, if
not identical, in nature and identity. Improvements in the dif-
ferentiation of hPSCs into fully committed midbrain dopamine
neurons have been attained by two recent studies (Kriks et al.,
2011; Kirkeby et al., 2012). Both employed sustained stimulation
of Wnt signaling (by inhibiting the enzyme glycogen synthase
kinase 3β, GSK-3β) to robustly induce the differentiation of
hPSCs into dopamine neurons (Figure 1). Neurons derived using
this protocol exhibited midbrain character, as confirmed by the
expression of the regional markers FoxA2 and Lmx1a (Kriks et al.,
2011; Kirkeby et al., 2012). Remarkably, transplantation of these
midbrain-specific dopamine neurons in the striatum resulted
in significant behavioral recovery in both rodent and primate
models of PD (Kriks et al., 2011; Kirkeby et al., 2012).
This transplantation strategy is designed to allocate trans-
planted dopamine neurons close to their physiological target
(striatal neurons) in order to facilitate their functional connec-
tivity, although grafted neurons would be ectopically located
regarding their natural midbrain position. It is unknown whether
this new neural circuit, its components necessarily re-organized,
can fully restore physiological function without any concomitant
behavioral alterations. To overcome this limitation, it would be
interesting to test whether hPSC-derived neurons transplanted in
the substantia nigra are able to re-establish nigro-striatal con-
nections. Although the adult brain parenchyma is minimally
permissive to axonal regrowth, grafted fetal dopaminergic neural
precursors are surprisingly capable of generating a nigro-striatal
pathway with an outgrowth pattern that matches the anatomy of
the intrinsic system (Thompson et al., 2009). These results reveal
some opportunities to reconstruct native neuronal circuits using a
cell transplantation approach in the adult brain. Whether a sim-
ilar approach can be envisioned using hPSC-derived dopamine
neurons remains to be demonstrated.
IN VITRO NEURONAL MATURATION AND AGING
In vitro differentiation of hPSCs into neurons is a long and multi-
step process that matches all of the stages of embryonic neuronal
commitment and differentiation. Therefore, the neurons that
result from hPSC induction appear to be very immature soon
after their specification; they acquire functional properties only
after several weeks in culture. Mature functional and synaptic
properties are observed in the majority of the hPSC-derived neu-
rons after 8–12 weeks of culture (Ricciardi et al., 2012; Verpelli
et al., 2013). Thus, this delay in functional maturation of the
hPSC-derived neurons in vitro certainly hampers the conduct of
functional studies using this system.
Supplementation of the culture medium with neurotrophins
and cAMP can enhance neuronal differentiation and restrain
cell death events (Soldner et al., 2009). However, a major differ-
entiating stimulus is provided when hPSC-derived neurons are
co-cultured on a primary astrocyte feeder layer. In fact, neuronal
differentiation, dendrite development, excitability, and synaptic
activity are all accelerated from 8- to 20-fold when hPSC-derived
neurons are cultured on astrocytes rather than on laminin (Tang
et al., 2013). Zhang et al. (2013) recently devised an interest-
ing alternative. They have shown that hPSC differentiation can
yield a high level of functional glutamatergic neuronal cells in
less than 2 weeks through the forced expression of only one tran-
scription factor, Neurogenin 2. This is an attractive procedure
because neurons are generated directly from naïve hPSCs in a
single manipulation step, thereby skipping all of the interme-
diate steps and saving time and labor. A similar approach has
been employed recently to accelerate the generation of functional
dopamine neurons by expressing the Ascl1, Nurr1, and Lmx1a
genes in naïve hPSCs (Theka et al., 2013).
As mentioned above, neurons derived from hPSCs require
time to mature fully and are comparable to cells at the imma-
ture fetal stage (Marchetto and Gage, 2012). This is particularly
troublesome when one aims to study the mechanisms of neuronal
aging and associated neurodegenerative disorders. In fact, neu-
ronal aging is amajor contributor to late-onset neurodegenerative
disorders and must be taken into account when modeling such
disorders. In order to model late-onset diseases, recent studies
have employed hPSC-derived neuronal in vitro cultures that have
been grown for up to 200 days (Dimos et al., 2008; Ebert et al.,
2009). hPSCs represent an interesting systemwith which to follow
changes in the morphological and functional properties of neu-
rons over a long period of time in vitro, possibly mimicking some
of the processes that occur during aging. However, new solu-
tions are needed to accelerate the aging process of these neurons
in vitro. Notably, a new approach has been recently proposed that
involves the expression of progerin, a truncated form of lamin-A
that is associated with premature aging (Miller et al., 2013). In
fact, the expression of progerin in hPSC-derived fibroblasts and
neurons induced multiple aging-related markers and character-
istics, including the appearance of neuromelanin in dopamine
neurons (Miller et al., 2013). It remains to be established which
features of late-onset disease can be authentically recapitulated by
the progerin-induced model in vitro. Similar to this study, other
known age-specific molecular pathways might be explored to
promote neuronal aging in vitro (Newgard and Sharpless, 2013).
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PATHOLOGICAL NEUROGENESIS: MODELING HUMAN
DISEASES USING NEURONS GENERATED IN VITRO
The advent of reprogramming adult human cells to become
human induced pluripotent stem cells (hiPSCs) has revealed new
opportunities to model disorders linked to a genetic cause. hiP-
SCs are able to self-renew and give rise to the affected somatic
cells, providing an unlimited source of informative material to
investigate diseases of interest. To date, a number of studies
have validated this approach, modeling both neurological and
neuropsychiatric disorders (Tiscornia et al., 2011; Zhu et al.,
2011; Sandoe and Eggan, 2013). Monogenic diseases in which
the mutated gene is known are particularly suitable for this
approach. In this scenario, the function of the gene of interest can
be restored, thus proving that the original mutation was indeed
the causative factor of the disease-specific phenotype (Soldner
et al., 2011; Liu et al., 2012). The approach is particularly relevant
because the individual genetic variability of human sample often
hampers any comparison between patient and healthy donor
cells, disabling the detection of phenotype differences (Saha and
Jaenisch, 2009). In fact, it would be necessary to analyze a large
cohort of control and patient cells in parallel in order to address
this matter, which would require a huge effort to generate and
analyze a large range of hiPSC lines. Some compelling studies have
been reported recently that illustrate the power of this approach
in helping to identify new cellular and molecular mechanisms of
disease; we report a few notable examples here.
Lee et al. (2010) developed an hiPSC model of familial dysau-
tonomia, a disorder that causes depletion of the autonomic and
sensory neurons, induced by mutations in the IKBKAP gene. In
the hiPSC system, they were able to correlate the loss of IKBKAP
gene expression with defects in neurogenesis and diminished cell
motility in hiPSC-derived neural crest cells. Similarly, Marchetto
et al. (2010) used neurons derived from the hiPSCs of individ-
uals affected by Rett syndrome (RTT), an autism-like disorder
caused by mutations in the methyl CpG binding protein MECP2.
Lack of MeCP2 protein in hiPSC-derived neurons was associated
with decreases in dendritic spines, synapses, and calcium oscil-
lation frequency, as well as a concurrent reduction in nuclear size
compared with control cells. Amore recent study used an isogenic
human embryonic stem cell model of RTT to identify a significant
reduction in nascent protein synthesis (Li et al., 2013). Moreover,
cells manifested a severe defect in AKT/mTOR pathway activ-
ity that resulted from the lack of MECP2 expression (Ricciardi
et al., 2011; Li et al., 2013). More interestingly, the activation
of AKT/mTOR signaling was sufficient to ameliorate the disease
phenotypes in mutant hiPSC-derived neurons, by boosting pro-
tein synthesis. These data clearly show how the hiPSC modeling
system is a convenient platform for the development of phar-
macologic and genetic approaches that aim to revert a mutant
phenotype using either a hypothesis-driven procedure or a more
systematic solution.
A relevant question is whether hiPSC-based modeling can be
fruitful for studying late-onset neurodegenerative diseases. In a
recent study, hiPSC-derived neurons from patients with genetic
or sporadic forms of Alzheimer disease (AD) did not exhibit
enhanced susceptibility to cell death or changes in activity com-
pared with controls (Israel et al., 2012). However, they did exhibit
significantly higher levels of the pathological markers amyloid-β,
phospho-Tau, and active GSK-3β than control cells. These hiPSC-
derived neurons from AD patients also accumulated large RAB5-
positive early endosomes compared with controls. Importantly,
treatment of purified neurons with β-secretase inhibitors, but not
γ-secretase inhibitors, caused significant reductions in phospho-
Tau and GSK-3β levels (Israel et al., 2012). Therefore, a direct
relationship can be drawn between the proteolytic processing of
amyloid precursor protein, but not that of amyloid-β, in GSK-3β
activation and Tau phosphorylation in hiPSC-derived neurons.
These data suggest that hiPSC technology can be used to observe
early pathological changes, possibly associated with the prodro-
mal phase of AD, even if it does not faithfully recapitulate the
phenotypes that characterize the late-onset phase.
NEURAL INDUCTION FROM A SINGLE LAYER TO THREE
DIMENSIONS
The employment of cutting-edge culture procedures has recently
elevated the potential of neural rosettes to recapitulate the
events and mechanisms that underlie neural tube development
to another dimension (Eiraku et al., 2008; Lancaster et al., 2013).
Studies have recently reported the generation of in vitro 3D cell
aggregates (organoids) that not only reproduce an organ’s struc-
ture, but also recapitulate its function and development (Sato
et al., 2009; Suga et al., 2011; Kadoshima et al., 2013). The applica-
tions of this technology to the investigation of still-unapproached
aspects of organogenesis promise to bear relevant knowledge that
is instrumental to a full understanding of tissue formation and
pathogenesis.
The possibility of modeling human brain disease in a Petri dish
(Eiraku et al., 2008) is certainly the most attractive, but innumer-
able implications can be imagined. Two different approaches have
attempted to reproduce corticogenesis (and, even more surpris-
ingly, brain morphogenesis) using hPSCs: quick re-aggregation
of cells was determinant in the first case (Eiraku et al., 2008;
Kadoshima et al., 2013), while larger and more complex struc-
tures (cerebral organoids) were achieved in the second case using
a spinning bioreactor (Lancaster et al., 2013). Each approach
generated a complex, multilayered structure that was able to
self-organize and possessed morphogenetic features highly rem-
iniscent of brain development. Among the most impressive: for-
mation of an apical and basal membrane and specification of
the anterior-posterior axis. Nonetheless, the specification of a
larger number of brain areas (e.g., sub-pallial structures) was only
detectable within cerebral organoids. This finding is particularly
relevant because it has permitted the recapitulation of a key pro-
cess of brain development that is highly correlated with numer-
ous cortical deficits, such as the invasion of the neocortex by
migrating GABAergic neurons originating in the sub-palladium.
Corticogenesis itself was also partially recapitulated in both
cellular systems. Cortical development is a highly dynamic and
complex process in which an internal layer of neuroepithelial pro-
genitors (the ventricular zone) generates post-mitotic neurons
that migrate and stratify in an inside-first outside-last fash-
ion depending on their birth date (Molyneaux et al., 2007). As
expected, the cardinal features of the neuroepithelial progenitors,
already identified in neural rosettes, were also observed in the
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apical or luminal side of 3D structures, where progenitors reside.
Further characterization of these cells revealed features typical of
radial glial cells (RGCs, late progenitors of the neocortex), such
as apical and basal processes. Moreover, a population of tran-
sient Tbr2-positive amplifying cells (which normally occupy the
sub-ventricular zone of the developing cortex) was also identified
adjacent to RGC-like cells. It is worth noting the description of
a third type of progenitors predominantly derived from human
cultures. The appearance of these cells (mainly characterized by
the absence of the apical process) is highly reminiscent of outer-
radial glial (oRG), an important hallmark of human neurogenesis
in contrast to murine neurogenesis. The abundance of these cells
in the developing human cortex has been associated with more
complex structural features, such as cortical gyrification; thus, the
presence of oRG-like cells indicates the faithful reproduction of
human corticogenesis in 3D culture.
The identification of a progeny of post-mitotic neurons that
form layers that are positioned basally over proliferative areas
according to their time of birth has further confirmed the iden-
tity of the progenitor niche. The distribution and specification of
post-mitotic neurons in quickly re-aggregated cells and in cere-
bral organoids has managed to recapitulate the early events of
corticogenesis, although the realization of a fully layered cor-
tex still remains to be established. Nonetheless, a simpler but
equally laminated neuroepithelial structure, the retina (Eiraku
et al., 2011; Nakano et al., 2012), was reproduced in vitro in
similar culture conditions, once again confirming the ability of
neuroepithelial cells to self-organize. The importance of this car-
dinal feature might lie in the ability of these cells to polarize
(and consequently, to form rosettes). It was recently suggested
that the same processes, polarization and rosette formation,
are fundamentally involved in epiblast specification and self-
organization, which emphasizes the intriguing hypothesis of a
possible common mechanism in tissue morphogenesis.
The advent of 3D cultures can significantly change the way
we see not only regenerative medicine, but also cell research en
bloc. Although this system can provide unique information, great
effort will have to be deployed to shepherd these expectations into
solid reality.
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